Global News

[ad_1] The Democratic Republic of the Congo (DRC), the "epicenter" of the ongoing Mpox outbreak in Africa, will launch its first phase of the vaccination campaign on October 2, the government has announced.  The vaccination effort, which runs until October 11, follows the receipt of over 265,000 doses from international partners, according to the minutes of the weekly Council of ministers meeting late Friday, Xinhua news agency reported. "The process of procuring 3,000 doses of vaccines for children is sufficiently advancing," the minutes said. A report released Friday by the Congolese Ministry of Health revealed that the DRC has reported 21,813 suspected cases. This includes 716 deaths since the start of 2024. The country accounts for about 90 per cent of cases in Africa. This comes as the World Health Organization (WHO) announced the approval of the MVA-BN vaccine, developed by Bavarian Nordic, as the first Mpox vaccine to its prequalification list.